secwatch / observer
8-K filed November 7, 2023, 6:59 PM ET ticker GMED CIK 0001237831
earnings confidence high sentiment positive materiality 0.70

Globus Medical Q3 revenue $383.6M (+51% YoY); raises FY revenue guidance to $1.55B

GLOBUS MEDICAL INC

2023-Q3 EPS reported $0.98 revenue$951,942,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

GLOBUS MEDICAL INC reported the quarter ended September 30, 2023 results: revenue $383.6 million, net income $1.0 million, EPS $0.01.

Period
the quarter ended September 30, 2023
Revenue
$383.6 million
Net income
$1.0 million
EPS
$0.01
Result
reported results
Exact text from the filing
merger with NuVasive, Inc. was completed on September 1, 2023 and results presented within include NuVasive, Inc. results from that closing date .  · Worldwide net sales were $ 383.6 million , an increase of 5 1.0 % . · GAAP net income for the quarter was $ 1.0 million · GAAP d iluted earnings per share (“ EPS ”) was $0. 0 1 and non-GAAP diluted EPS was $0. 57 ·
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

GLOBUS MEDICAL INC reported full year fiscal 2023 results: revenue $1.55 billion, EPS $2.30. Guidance raised.

Period
full year fiscal 2023
Revenue
$1.55 billion
EPS
$2.30
Guidance
raised
Result
guidance update
Exact text from the filing
The Company today increased its full year fiscal 2023 revenue guidance to $1.55 billion, up from $1.125 billion, and reaffirmed non-GAAP fully diluted earnings per share guidance of $2.30.
View on SEC.gov

Browse all earnings releases →

GLOBUS MEDICAL INC filing history →

Source: SEC EDGAR
accession 0001562762-23-000405
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.